Injective (INJ) has received a strong fundamental boost after Coinbase finalized the migration to the token’s native network. The exchange automatically converted all ERC-20 based INJ balances on a one-to-one basis, enabling direct deposits, withdrawals, and trading on Injective’s own blockchain. This removes the need for Ethereum bridges and gives both retail and institutional users seamless access to the Injective ecosystem.
The technical upgrade is powered by Injective’s MultiVM Token Standard (MTS), which keeps assets interoperable across virtual machine environments while presenting users with a unified balance. Coinbase’s move reduces liquidity fragmentation and operational hurdles for anyone interacting with decentralized finance applications on Injective.
Market reaction has been visibly positive. Although INJ pulled back slightly after spiking to an intraday high near $5.60, it continues to trade around $5.14–$5.38, up roughly 19.5% over the past 30 days. Technical indicators such as RSI (64) and MACD (0.035) are flashing buy signals, while the Ultimate Oscillator (60.03) points to stronger buying pressure. Key support sits in the $4.50–$3.50 zone, and a sustained move above the $5.67–$6.99 resistance band would be a notable structural shift. For now, analysts are watching whether current momentum can carry INJ through that next hurdle.
